In a groundbreaking move poised to reshape the healthcare landscape in India, Indegene, a digital-first life sciences commercialization company, has launched Cortex, a fit-for-purpose Generative AI (GenAI) platform designed specifically for the life sciences industry. This cutting-edge platform aims to streamline key processes, accelerate innovation, and enhance operational efficiency for healthcare and pharmaceutical leaders.

Cortex by Indegene stands out as a life sciences-specialist knowledge engineering and multi-agent orchestration platform, empowering life sciences organizations to scale GenAI adoption with enterprise-grade governance. By leveraging the company’s 25+ years of subject matter expertise, Cortex employs advanced knowledge graphs to deliver tailored solutions that address critical industry challenges, including content supply chain optimization, efficient medical writing, and faster Medical-Legal-Regulatory (MLR) reviews.

“Life sciences leaders believe in GenAI’s potential to transform and modernize their commercialization processes,” said Manish Gupta, Chairperson and CEO of Indegene. “They also demand an enterprise-grade platform that assures them of the security, governance, scalability and business value essential to adopting technology across the enterprise. With this GenAI platform, we codify our 25+ years of practitioner experience letting life sciences leaders make the most of this transformative technology.”

One of Cortex’s standout features is its multi-agent orchestration, which allows for seamless enterprise-wide system integration. The platform’s fit-for-purpose agents can be configured with any preferred Large Language Model (LLM) and evolve alongside advancements in LLM technology. This flexibility ensures continuous improvement, delivering more reliable, accurate, and trustworthy outcomes compared to industry-agnostic platforms.

“Life sciences leaders demand an AI infrastructure that adapts to new business models, processes and experiences,” added Tarun Mathur, CTO of Indegene. “Our new GenAI platform empowers them to develop their own intellectual property (IP), leveraging Indegene’s technology and knowledge engineering practices. We look forward to supporting the wide number of use cases they apply this exciting technology to and the value they realize in the process.”

Also Read :- KKR Grabs 54% Stake in HCG – How This Billion Dollar Deal Redefines Indian Healthcare

For the healthcare industry in India, Cortex represents a significant leap forward. The platform not only enhances efficiency but also supports the creation of personalized, scalable, and omnichannel experiences for both patients and healthcare providers. By streamlining regulatory processes, improving content workflows, and enhancing decision-making through data-driven insights, Cortex empowers healthcare organizations to be future-ready, aligning with India’s broader digital health transformation goals.

The platform’s impact has already garnered recognition from leading industry analysts. HFS Research, a global business research consultancy, recognized Indegene as a Horizon 3 OneEcosystem Exponential Leader for leveraging GenAI to collaborate across the life sciences and healthcare ecosystem. Similarly, Everest Group identified Indegene as a Front-Runner for its success in scaling GenAI, building industry-specific partnerships, and delivering tangible value.

As India’s healthcare industry continues to embrace digital transformation, platforms like Cortex will play a pivotal role in driving innovation, improving outcomes, and optimizing costs. For healthcare leaders and organizations seeking to modernize their commercialization processes, Cortex offers a powerful solution to navigate the future of life sciences with confidence and efficiency.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!